Nathan Rich

Stock Analyst at Goldman Sachs

(0.99)
# 3,872
Out of 5,044 analysts
84
Total ratings
35.48%
Success rate
-10.16%
Average return

Stocks Rated by Nathan Rich

Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16$21
Current: $19.67
Upside: +6.76%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223$196
Current: $147.53
Upside: +32.85%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34$30
Current: $13.09
Upside: +129.18%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25$8
Current: $10.25
Upside: -21.95%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20$18
Current: $20.35
Upside: -14.00%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450$385
Current: $292.34
Upside: +31.70%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13$14
Current: $22.27
Upside: -37.14%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10$11
Current: $19.61
Upside: -43.91%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197$225
Current: $135.65
Upside: +65.87%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500$650
Current: $647.40
Upside: +0.40%
Maintains: Buy
Price Target: $100$88
Current: $82.45
Upside: +6.73%
Maintains: Buy
Price Target: $14$12
Current: $17.77
Upside: -32.47%
Downgrades: Neutral
Price Target: $93$85
Current: $63.54
Upside: +33.77%
Maintains: Neutral
Price Target: $10$11
Current: $10.42
Upside: +5.57%
Initiates: Buy
Price Target: $335
Current: $162.19
Upside: +106.55%
Initiates: Buy
Price Target: $535
Current: $365.98
Upside: +46.18%